Published in Am J Gastroenterol on February 01, 2002
Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc (2006) 1.13
Hepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections: A review of the evidence and current recommendations. Can J Infect Dis Med Microbiol (2008) 0.86
Bloodborne viral hepatitis infections among drug users: the role of vaccination. Int J Environ Res Public Health (2009) 0.85
Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults. Hum Vaccin Immunother (2015) 0.84
Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin treatment. World J Gastroenterol (2006) 0.80
Four-year follow up of hepatitis C patients vaccinated against hepatitis B virus. World J Gastroenterol (2005) 0.78
Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World J Hepatol (2015) 0.77
Suitable hepatitis B vaccine for adult immunization in China. Immunol Res (2016) 0.77
Management of the Cirrhotic Patient Before Liver Transplantation: The Role of the Referring Gastroenterologist. Gastroenterol Hepatol (N Y) (2006) 0.75
Emerging Trends in Epidemiology of Hepatitis B Virus Infection. J Clin Transl Hepatol (2017) 0.75
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol (2003) 2.18
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev (2002) 1.49
Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation. Liver Transpl (2003) 1.19
Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology (2004) 1.10
Estrogen receptor classification for hepatocellular carcinoma: comparison with clinical staging systems. J Clin Oncol (2003) 1.10
Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl (2004) 1.05
Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients. Sex Transm Dis (2007) 1.04
Variant estrogen receptors and their role in liver disease. Mol Cell Endocrinol (2002) 0.99
Elevated monocyte chemoattractant protein-1 levels following thermal injury precede monocyte recruitment to the wound site and are controlled, in part, by tumor necrosis factor-alpha. Wound Repair Regen (2003) 0.99
The early acute phase response after burn injury in mice. J Burn Care Res (2007) 0.92
Cirrhotic ascites review: Pathophysiology, diagnosis and management. World J Hepatol (2013) 0.91
Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C. J Med Virol (2002) 0.91
Current concepts and management approaches in nonalcoholic fatty liver disease. ScientificWorldJournal (2013) 0.91
Reactivation of sarcoidosis during interferon therapy. J Gastroenterol (2002) 0.90
Continuous peritoneal drainage of large-volume ascites. Dig Dis Sci (2011) 0.90
Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantation. Liver Transpl (2002) 0.89
Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation. Clin Transplant (2003) 0.88
Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis. Eur J Gastroenterol Hepatol (2008) 0.87
Liver transplantation for alcoholic liver disease. Alcohol Res Health (2003) 0.87
Hepatic apoptosis and proliferation in male and female rats fed alcohol: role of cytokines. Alcohol Clin Exp Res (2003) 0.87
Impaired response to high-dose interferon treatment in African-Americans with chronic hepatitis C. Hepatogastroenterology (2002) 0.85
Hepatic estrogen receptors and alcohol intake. Mol Cell Endocrinol (2002) 0.85
Biomarkers of Oxidative Stress Study IV: ozone exposure of rats and its effect on antioxidants in plasma and bronchoalveolar lavage fluid. Free Radic Biol Med (2011) 0.84
Hepatocellular carcinoma: role of estrogen receptors in the liver. Ann N Y Acad Sci (2002) 0.83
Nodular regenerative hyperplasia of liver as a consequence of ART. AIDS (2007) 0.83
Atypical presentation and etiology of left-sided portal hypertension. Dig Dis Sci (2007) 0.82
Post-transplant IVC occlusion and thrombosis treated with tPA, heparin, and sharp recanalization. J Gastroenterol (2005) 0.81
Frequency of peritoneal infections among patients undergoing continuous paracentesis with an indwelling catheter. J Ayub Med Coll Abbottabad (2011) 0.81
Cryoglobulinaemia and autoimmune markers in hepatitis C virus infected patients on renal replacement therapy. J Pak Med Assoc (2007) 0.81
Consensus interferon induced interstitial pneumonitis in a patient with HCV. Am J Gastroenterol (2006) 0.81
Cholestatic jaundice and IgA nephropathy induced by OTC muscle building agent superdrol. Am J Gastroenterol (2006) 0.80
Consensus interferon used to treat prior partial-responders to pegylated interferon plus ribavirin. Dig Dis Sci (2011) 0.80
A comparison of risk factors for HCV-mono-infection, HIV-mono-infection, and HCV/HIV-co-infection in a community setting. Dig Dis Sci (2007) 0.80
Indexed left atrial volume is superior to left atrial diameter in predicting nonvalvular atrial fibrillation recurrence after successful cardioversion: a prospective study. Echocardiography (2011) 0.79
Luminescence experiments involved in the mechanism of streptozotocin diabetes and cataract formation. Luminescence (2008) 0.79
Effects of soybean extract on morphology and survival of Caco-2, SW620, and HT-29 cells. Nutr Cancer (2002) 0.79
Cardiovascular problems in cirrhotic patients. Turk J Gastroenterol (2004) 0.79
Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci (2003) 0.79
Hepatitis C virus-associated pericardial effusion and tamponade in a liver transplant recipient. Can J Cardiol (2004) 0.79
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support. ASAIO J (2002) 0.79
Daily interferon therapy for chronic hepatitis C: a report of a community practice experience. Hepatogastroenterology (2002) 0.78
Ultrasensitive peroxynitrite-based luminescence with L-012 as a screening system for antioxidative/antinitrating substances, e.g. Tylenol (acetaminophen), 4-OH tempol, quercetin and carboxy-PTIO. Luminescence (2007) 0.78
Prochlorperazine-induced cholestasis in a patient with alpha-1 antitrypsin deficiency. Hepatogastroenterology (2003) 0.78
Use of recombinant factor VIIa to correct the coagulation status of individuals with advanced liver disease prior to a percutaneous liver biopsy. Dig Dis Sci (2009) 0.78
Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma. Hepatogastroenterology (2004) 0.78
Liver transplantation for fulminant hepatic failure. J Gastroenterol (2002) 0.77
Hemostatic modulation with the liver dialysis device in humans with advanced liver disease. Hepatogastroenterology (2002) 0.77
Transjugular liver biopsy: comparison of sample adequacy with the use of two automated needle systems. J Vasc Interv Radiol (2010) 0.77
Amelioration of hypertrophic cardiomyopathy using nonsurgical septal ablation in a cirrhotic patient prior to liver transplantation. Liver Transpl (2005) 0.77
Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study. Cytokine (2004) 0.77
Endoscopic ultrasound with biopsy of omental mass for cholangiocarcinoma diagnosis in cirrhosis. World J Gastrointest Endosc (2011) 0.77
Celiac disease in patients with HCV genotype 1A. Am J Gastroenterol (2003) 0.77
Calponin is expressed by Sertoli cells within rat testes and is associated with actin-enriched cytoskeleton. Cell Tissue Res (2004) 0.76
Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals. Hepatogastroenterology (2003) 0.76
HELLP syndrome complicated bile duct injury and subsequent left hepatic lobe atrophy. Dig Dis Sci (2006) 0.76
Complex regional pain syndrome (reflex sympathetic dystrophy) in a patient with essential mixed cryoglobulinemia and chronic hepatitis C. J Pak Med Assoc (2007) 0.76
Use of endoscopic ultrasound for diagnosis of cholangiocarcinoma in auto-immune hepatitis. World J Gastrointest Endosc (2010) 0.75
Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. Clin Transplant (1993) 0.75
TIPS versus paracentesis for the treatment of refractory ascites. Hepatology (2004) 0.75
Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome. Dig Dis Sci (2003) 0.75
Travel: a unique risk factor for acute hepatitis C virus. MedGenMed (2006) 0.75
Colonic diffuse large B-cell lymphoma in a liver transplant patient with historically very low tacrolimus levels. Case Rep Transplant (2012) 0.75
Nonocclusive mesenteric ischemia: reality. J Gastroenterol (2002) 0.75
Complete esophagogastric anastomotic disruption. Gastrointest Endosc (2003) 0.75
Ascites and kidney transplantation: case report and critical appraisal of the literature. Dig Dis Sci (2007) 0.75
Vanishing Bile Ducts, Cholesatatic Jaundice and Portal Hypertension Secondary to Hepatic ALECT-2 Amyloid Deposition. J Clin Gastroenterol (2017) 0.75
First report of telaprevir-induced pancreatitis. Dig Dis Sci (2013) 0.75
Retroperitoneal varices presenting as an adrenal pseudotumor in a cirrhotic patient. WMJ (2006) 0.75
Successful removal of cecal stones by using a colonoscope in an individual with repeated lithophagia. Gastrointest Endosc (2008) 0.75
Hepatic iron quantitation and its relationship with disease measures and histologically assessed iron content. Dig Dis Sci (2007) 0.75
An assessment of the accuracy of hepatic and splenic size based upon a clinician's physical examination, a radiologist's impression and the actual liver and spleen volumes calculated by CT scanning. Dig Dis Sci (2008) 0.75
Daily interferon monotherapy for chronic hepatitis C in patients with normal or near-normal serum alanine transaminase levels: a comparison of two protocols. South Med J (2005) 0.75
Adenocarcinoma of the ileocecal valve occurring 35 years after jejunoileal bypass. South Med J (2008) 0.75
Predictors of depression in patients presenting with dyspeptic symptoms in a GI clinic. J Ayub Med Coll Abbottabad (2013) 0.75
Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient. Chest (2003) 0.75
Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa. Hepatogastroenterology (2003) 0.75
Helicobacter pylori prevalence and histopathological findings in dyspeptic patients. J Ayub Med Coll Abbottabad (2015) 0.75
Postoperative infections in cirrhotic patients. Hepatogastroenterology (2005) 0.75